Clinton Group’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-40,571
Closed -$514K 926
2017
Q1
$514K Sell
40,571
-37,904
-48% -$449K 0.03% 620
2016
Q4
$801K Buy
78,475
+1,271
+2% +$14.5K 0.05% 419
2016
Q3
$1.02M Buy
+77,204
New +$1.03M 0.05% 459
2016
Q2
Sell
-120,430
Closed -$1.59M 1074
2016
Q1
$1.59M Buy
+120,430
New +$1.58M 0.1% 316
2015
Q3
Sell
-16,469
Closed -$225K 863
2015
Q2
$225K Buy
+16,469
New +$222K 0.03% 523

Other funds holding MDRX

Clinton Group's MDRX Position: Q2 2017 in Review

Clinton Group sold out of Veradigm Inc. Common Stock (MDRX) in Q2 2017, closing a stake of 40,571 shares — an estimated $514K sold.

Clinton Group first reported a position in MDRX in Q2 2015 and held it in 5 quarters. The position peaked at $1.59M in Q1 2016. 232 funds tracked by Wall St. Rank hold MDRX as of Q2 2017.

  • Clinton Group reported no remaining Veradigm Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Clinton Group sold 40,571 Veradigm Inc. Common Stock shares in Q2 2017, an estimated $514K.
  • Clinton Group first reported a position in Veradigm Inc. Common Stock in Q2 2015 and held it in 5 quarters.
  • Clinton Group's Veradigm Inc. Common Stock position peaked at $1.59M in Q1 2016.
  • 232 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q2 2017.

Based on Clinton Group's 13F filing for Q2 2017, filed 14 Aug 2017.